Viking Therapeutics：神秘的 GLP-1 参与者及其关键催化剂（第二季度财报）(VKTX)
· seekingalpha.com
随着 GLP-1 减肥药竞争加剧，Viking Therapeutics 股价持稳。在此阅读最新的财报分析。
If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and ...